Crossmark

Emodin-loaded polymer-lipid hybrid nanoparticles enhance the sensitivity of breast cancer to doxorubicin by inhibiting epithelial–mesenchymal transition

Crossref DOI link: https://doi.org/10.1186/s12645-021-00093-9

Published Online: 2021-08-11

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zou, Tengteng

Lan, Meng

Liu, Fengjie

Li, Lihong

Cai, Tiange

Tian, Huaqin

Cai, Yu http://orcid.org/0000-0002-8532-7816
Funding

Funding for this research was provided by:

Natural Science Foundation of Guangdong Province (2021A1515011241)
License Information

Text and Data Mining valid from 2021-08-11

Version of Record valid from 2021-08-11
More Information

Article History

Received: 29 April 2021

Accepted: 28 July 2021

First Online: 11 August 2021

Declarations

:

: Not applicable.

: All authors agree with the publication of this manuscript in this journal.

: The authors declare that there is no conflict of interest.

Document is current

Any future updates will be listed below